Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
Obesity is typically assessed by measuring someone's body mass index, but now researchers are calling for a more nuanced ...
By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts ...
The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...
A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...
Fitness outranks weight in predicting mortality risk, as new studies show high fitness levels reduce early death risks ...
Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...